Company news
Ecs Botanics Holdings Ltd (ASX:ECS) news
Ecs Botanics Holdings Ltd news releases on 6ix. Latest, Oct 6, 2026: ECS Launches UK Branded Portfolio with Curaleaf
Press releases & updates
ECS Launches UK Branded Portfolio with Curaleaf
October 6, 2026
ECS FY26 Results
August 27, 2026
ECS launches All-In-One Vapes
July 26, 2026
German GMP Update Reinforces ECS Manufacturing Strategy
July 2, 2026
ECS Launches First Australian-Grown Terphogz Product
June 21, 2026
H1 FY26 Results-Return to Profitability & Positive Cashflow
February 27, 2026
Half Yearly Report and Accounts
February 27, 2026
ECS Enters German Distribution Partnership with OzSun
February 10, 2026
Security Class Reinstatement to Quotation - ECSO
January 30, 2026
Security Class Suspension from Quotation - ECSO
January 29, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 13, 2026
ECS BOTANICS ADVANCES PREPARATIONS FOR US MARKET ENTRY
December 15, 2025
ECS launches Woman Health Brand
December 3, 2025
ECS Launches Sugar-Free Gummies as B2C Sales Surpass 60%
November 20, 2025
ECS successfully completes $1.95m placement
November 12, 2025
Trading Halt
November 10, 2025
ECS FY25 Results
August 29, 2025
Appendix 4E & Annual Report
August 29, 2025
ECS to support UWA medicinal cannabis clinical trial
July 6, 2025
Terphogz Launch
June 29, 2025
Record Harvest and Expansion of Premium B2C Product Line
May 16, 2025
Quarterly Activities/Appendix 4C Cash Flow Report (amended)
April 28, 2025
ECS Secures Additional Growth Funding
April 13, 2025
ECS Half Year FY25 Results
February 27, 2025
ECS Achieves 50% Yield Increase with New PCEs
December 15, 2024
ECS loan increase by NAB and VESIsorb launch
November 20, 2024
Business to Consumer Commercial Update
November 14, 2024
Notice of Annual General Meeting/Proxy Form
October 16, 2024
ECS secures exclusive agreement with Terphogz
September 17, 2024
FY24 Results - Record Harvest, Profit and Revenue
August 27, 2024
ECS Secures Manufacturing Grant & NAB Finance for Expansion
July 7, 2024
ECS launches B2C sales
May 17, 2024
Board Change and Director Interest Notices
May 5, 2024
ECS achieves profitable half year results
February 27, 2024
Germany legalises Cannabis
February 26, 2024
ECS to execute expansion plans following $4m Placement.
February 21, 2024
ECS secures $9 million UK offtake agreement
January 31, 2024
ECS launches Vapes and Pastilles
November 12, 2023
$24 Million Supply Agreement with Medicann Health
October 2, 2023
FY23 Full-Year Results - ECS Achieves Positive EBITDA
August 31, 2023
Appendix 4E
August 31, 2023
ECS secures Australian supply agreements worth $11.9m
June 25, 2023
HY Report - Strategy Drives Record Financial Performance
February 27, 2023
Monthly Activities/Appendix 4C Cash Flow Report
January 15, 2023
ECS Secures $9.9m Supply Agreement into Germany
January 3, 2023
Victorian Flood Update
November 6, 2022
Sale Completion of Tasmanian Assets
November 3, 2022
Sale of Tasmanian Assets
October 23, 2022
Appendix 4E Preliminary Final Report
August 31, 2022
Non-dilutive funding and asset sale update
July 21, 2022